Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
43.48
-0.17 (-0.39%)
Dec 3, 2024, 12:43 PM EST - Market open
Qiagen Employees
Qiagen had 5,967 employees as of December 31, 2023. The number of employees decreased by 211 or -3.42% compared to the previous year.
Employees
5,967
Change (1Y)
-211
Growth (1Y)
-3.42%
Revenue / Employee
$329,508
Profits / Employee
$15,574
Market Cap
9.66B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5,967 | -211 | -3.42% |
Dec 31, 2022 | 6,178 | 150 | 2.49% |
Dec 31, 2021 | 6,028 | 418 | 7.45% |
Dec 31, 2020 | 5,610 | 514 | 10.09% |
Dec 31, 2019 | 5,096 | 144 | 2.91% |
Dec 31, 2018 | 4,952 | 264 | 5.63% |
Dec 31, 2017 | 4,688 | 4 | 0.09% |
Dec 31, 2016 | 4,684 | 125 | 2.74% |
Dec 31, 2015 | 4,559 | 220 | 5.07% |
Dec 31, 2014 | 4,339 | 324 | 8.07% |
Dec 31, 2013 | 4,015 | 16 | 0.40% |
Dec 31, 2012 | 3,999 | 61 | 1.55% |
Dec 31, 2011 | 3,938 | 351 | 9.79% |
Dec 31, 2010 | 3,587 | 92 | 2.63% |
Dec 31, 2009 | 3,495 | 454 | 14.93% |
Dec 31, 2008 | 3,041 | 379 | 14.24% |
Dec 31, 2007 | 2,662 | 708 | 36.23% |
Dec 31, 2006 | 1,954 | 365 | 22.97% |
Dec 31, 2005 | 1,589 | 267 | 20.20% |
Dec 31, 2004 | 1,322 | -231 | -14.87% |
Dec 31, 2003 | 1,553 | -98 | -5.94% |
Dec 31, 2002 | 1,651 | 94 | 6.04% |
Dec 31, 2001 | 1,557 | 242 | 18.40% |
Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Charles River Laboratories International | 21,800 |
Bio-Rad Laboratories | 8,030 |
Bio-Rad Laboratories | 8,030 |
Penumbra | 4,200 |
Tempus AI | 1,952 |
Roivant Sciences | 908 |
QGEN News
- 5 days ago - QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing - Business Wire
- 5 days ago - QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis - GlobeNewsWire
- 25 days ago - Qiagen N.V. (QGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters
- 4 weeks ago - QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewsWire
- 5 weeks ago - QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment - GlobeNewsWire
- 7 weeks ago - QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications - GlobeNewsWire
- 7 weeks ago - QIAGEN N.V. to release results for Q3 2024 and hold webcast - GlobeNewsWire